NASDAQ : QUCY
Mainz Biomed N.V. — Key statistics
Germany
Last price 0.91 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 76.50M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 70.62M |
| Enterprise Value | 57.41M |
Dates
| Measure | Value |
|---|
| Earnings Date | Aug 14, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 84.07M |
| Shares Outstanding | 84.07M |
| Shares Change (YoY) | +331.43% |
| Shares Change (QoQ) | +51.29% |
| Owned by Insiders (%) | 68.45% |
| Owned by Institutions (%) | 0.31% |
| Float | 24.34M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 131.48 |
| Forward PS | 13.58 |
| PB Ratio | 1.03 |
| P/TBV Ratio | 5.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 106.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 5.56 |
| Quick Ratio | 4.51 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -56.47 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -212.53% |
| Return on Assets (ROA) | -64.88% |
| Return on Invested Capital (ROIC) | -82.30% |
| Return on Capital Employed (ROCE) | -84.55% |
| Weighted Average Cost of Capital (WACC) | 17.91% |
| Revenue Per Employee | $41,314 |
| Profits Per Employee | -$1.83M |
| Employee Count | 13 |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 2.43 |
| 52-Week Price Change | -42.47% |
| 50-Day Moving Average | 1.27 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 32.48 |
| Average Volume (20 Days) | 530,039 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.25M |
| Short Previous Month | 1.61M |
| Short % of Shares Out | 1.48% |
| Short % of Float | 5.12% |
| Short Ratio (days to cover) | 2.49 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 537,080 |
| Gross Profit | 389,792 |
| Operating Income | -17.22M |
| Pretax Income | -24.32M |
| Net Income | -23.83M |
| EBITDA | -16.56M |
| EBIT | -17.22M |
| Loss Per Share | -$2.08 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 13.38M |
| Total Debt | 168,670 |
| Net Cash | 13.21M |
| Net Cash Per Share | $0.16 |
| Equity (Book Value) | 20.36M |
| Book Value Per Share | 0.81 |
| Working Capital | 13.69M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -14.25M |
| Capital Expenditures | -137,457 |
| Depreciation & Amortization | 661,306 |
| Net Borrowing | -1.81M |
| Free Cash Flow | -14.39M |
| FCF Per Share | -$0.17 |
Margins
| Measure | Value |
|---|
| Gross Margin | 72.58% |
| Operating Margin | -3,205.62% |
| Pretax Margin | -4,528.04% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -331.43% |
| Shareholder Yield | n/a |
| Earnings Yield | -247.37% |
| FCF Yield | -20.38% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | 220.91% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Dec 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:40 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -6.46 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |